Cytomegalovirus encephalitis/retinitis in allogeneic haematopoietic stem cell transplant recipient treated successfully with combination of cidofovir and foscarnet

被引：15
|
作者：
Hubacek, Petr [1 ]
Keslova, Petra [1 ]
Formankova, Renata [1 ]
Pochop, Pavel [2 ]
Cinek, Ondrej [3 ]
Zajac, Miroslav [4 ]
Lochmanova, Jana [5 ,6 ]
Stary, Jan [1 ]
Sedlacek, Petr [1 ]
机构：
[1] Charles Univ Prague, Dept Paediat Haematol & Oncol, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[2] Charles Univ Prague, Dept Ophthalmol Children & Adults, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[3] Charles Univ Prague, Dept Paediat, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[4] Charles Univ Prague, Dept Microbiol, Sch Med 2, Motol Univ Hosp, CZ-15006 Prague 5, Czech Republic
[5] Univ Hosp Brno, Ctr Mol Biol & Gene Therapy, Dept Internal Med, Brno, Czech Republic
[6] Masaryk Univ, Brno, Czech Republic
来源：
PEDIATRIC TRANSPLANTATION | 2009年 / 13卷 / 07期
关键词：
cytomegalovirus; transplantation; ganciclovir resistance; cidofovir; foscarnet; PHARMACOKINETIC PROPERTIES; IMMUNOCOMPROMISED PATIENTS; ANTIVIRAL ACTIVITY; THERAPEUTIC USE; GANCICLOVIR; INFECTION;
D O I：
10.1111/j.1399-3046.2008.01070.x
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
We report an 18-yr-old female patient with repeated CMV reactivations after HSCT treated by several pre-emptive courses of virostatic therapy. Seven months after HSCT, she developed CMV encephalitis/retinitis. Initial therapy with GCV and hyperimmune globulin failed, and later on GCV-resistant strain was detected. Continual increase of CMV DNA in peripheral blood led us to combined therapy with CDV and FCV, which was successful and free of severe renal toxicity. To our best knowlegde, this is the first reported case of successful CMV treatment with a combination of CDV and FCV.
引用
收藏
页码：919 / 922
页数：4
相关论文
共 50 条
  • [31] Cytomegalovirus Retinitis in a Hematopoietic Stem Cell Transplant Recipient During Maribavir Pre-emptive Therapy
    Jang, Hyeon Mu
    Park, Han-Seung
    Sung, Heungsup
    Kim, Sung-Han
    INFECTION AND CHEMOTHERAPY, 2025, 57 (01): : 168 - 171
  • [32] Severe encephalitis in a haematopoietic stem cell transplant recipient caused by reactivation of human herpesvirus 6 and 7
    Holden, Stephen R.
    Vas, Anna L.
    JOURNAL OF CLINICAL VIROLOGY, 2007, 40 (03) : 245 - 247
  • [33] Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin
    Madureira, A.
    Bergeron, A.
    Lacroix, C.
    Robin, M.
    Rocha, V.
    Peffault de latour, R.
    Ferry, C.
    Devergie, A.
    Lapalu, J.
    Gluckman, E.
    Socie, G.
    Ghannoum, M.
    Ribaud, P.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S172 - S172
  • [34] Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin
    Madureira, Adrienne
    Bergeron, Anne
    Lacroix, Claire
    Robin, Marie
    Rocha, Vanderson
    de Latour, Regis Peffault
    Ferry, Christele
    Devergie, Agnes
    Lapalu, Jordane
    Gluckman, Eliane
    Socie, Gerard
    Ghannoum, Mahmoud
    Ribaud, Patricia
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (06) : 551 - 554
  • [35] De novo ganciclovir-resistant cytomegalovirus treated with foscarnet in a pediatric renal transplant recipient
    McLean, Nadia
    Robinson, Lisa
    Williams, Angela
    Teoh, Chia-Wei
    Yau, Yvonne
    Hebert, Diane
    PEDIATRIC TRANSPLANTATION, 2019, 23
  • [36] Foscarnet in the management of cytomegalovirus infections in hematopoietic stem cell transplant patients
    Bacigalupo, Andrea
    Boyd, Alan
    Slipper, Jackie
    Curtis, Jim
    Clissold, Steve
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (11) : 1249 - 1264
  • [37] Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant
    Lazzari, Lorenzo
    Oltolini, Chiara
    Ciceri, Fabio
    Giglio, Fabio
    BMJ CASE REPORTS, 2021, 14 (10)
  • [38] Cidofovir Is a Highly Effective and Safe Salvage Therapy in Ganciclovir Resistant Cytomegalovirus Reactivation Following Allogeneic Haematopoietic Stem Cell Transplantation
    Lewis, David
    Farina, Francesca
    Nagra, Sandeep
    Chaganti, Sridhar
    Pachnio, Annette
    Nunnick, Jane
    Moss, Paul A. H.
    Malladi, Ram
    Craddock, Charles F.
    BLOOD, 2012, 120 (21)
  • [39] Cidofovir for cytomegalovirus-preemptive therapy in stem cell transplant recipients
    Kiehl, MG
    Basara, N
    BLOOD, 2001, 98 (05) : 1626 - 1626
  • [40] Valganciclovir as pre-emptive therapy for cytomegalovirus infection in allogeneic haematopoietic stem cell transplant recipients
    Ruiz-Camps, Isabel
    Len, Oscar
    de la Camara, Rafael
    Gurgui, Mercedes
    Martino, Rodrigo
    Jarque, Isidro
    Barrenetxea, Cristina
    Diaz de Heredia, Cristina
    Batlle, Montserrat
    Rovira, Montserrat
    de la Torre, Julian
    Torres, Antonio
    Aguilar, Manuela
    Espigado, Ildefonso
    Martin-Davila, Pilar
    Bou, German
    Borrell, Nuria
    Maria Aguado, Jose
    Pahissa, Albert
    ANTIVIRAL THERAPY, 2011, 16 (07) : 951 - 957
12345